nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2010 |
38 |
1 |
p. IFC- 1 p. |
artikel |
2 |
Alternative strategies in assuring blood safety: An Overview
|
Epstein, Jay S. |
|
2010 |
38 |
1 |
p. 31-35 5 p. |
artikel |
3 |
Blood donation in Chile: Replacement and volunteer donors
|
Herrera, Claudia |
|
2010 |
38 |
1 |
p. 36-38 3 p. |
artikel |
4 |
Characterization of variant diphtheria toxin–interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials
|
Su, Yunpeng |
|
2010 |
38 |
1 |
p. 144-149 6 p. |
artikel |
5 |
Cloning and expression of a region of vesicle associated membrane protein2 (VAMP2) gene and its use as a recombinant peptide substrate for assaying clostridial neurotoxins in contaminated biologicals
|
Moghaddam, Mehrdad Moosazadeh |
|
2010 |
38 |
1 |
p. 113-119 7 p. |
artikel |
6 |
Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products
|
Goodrich, Raymond P. |
|
2010 |
38 |
1 |
p. 20-30 11 p. |
artikel |
7 |
Donor issues in Indonesia: A developing country in South East Asia
|
Soedarmono, Yuyun S.M. |
|
2010 |
38 |
1 |
p. 43-46 4 p. |
artikel |
8 |
Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations
|
Knezevic, I. |
|
2010 |
38 |
1 |
p. 162-169 8 p. |
artikel |
9 |
Filler Ad: Mode of Action of Adjuvants
|
|
|
2010 |
38 |
1 |
p. ii- 1 p. |
artikel |
10 |
Foreword
|
Allain, Jean-Pierre |
|
2010 |
38 |
1 |
p. 1- 1 p. |
artikel |
11 |
Fostering repeat donations in Ghana
|
Owusu-Ofori, S. |
|
2010 |
38 |
1 |
p. 47-52 6 p. |
artikel |
12 |
Health economics of blood transfusion safety – focus on sub-Saharan Africa
|
van Hulst, Marinus |
|
2010 |
38 |
1 |
p. 53-58 6 p. |
artikel |
13 |
Hemovigilance in developing countries
|
Ayob, Yasmin |
|
2010 |
38 |
1 |
p. 91-96 6 p. |
artikel |
14 |
How safe is blood, really?
|
Klein, Harvey G. |
|
2010 |
38 |
1 |
p. 100-104 5 p. |
artikel |
15 |
Improving availability and affordability of plasma-derived medicines
|
Cheraghali, Abdol Majid |
|
2010 |
38 |
1 |
p. 81-86 6 p. |
artikel |
16 |
Influence of ethanol on the release of growth factors in human blood-derived platelet gels
|
Kuo, Ya Po |
|
2010 |
38 |
1 |
p. 120-127 8 p. |
artikel |
17 |
l-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions
|
Bolli, Reinhard |
|
2010 |
38 |
1 |
p. 150-157 8 p. |
artikel |
18 |
Management of blood system in disasters
|
Kuruppu, Kumudu K.S. |
|
2010 |
38 |
1 |
p. 87-90 4 p. |
artikel |
19 |
Material & equipment, procurement & maintenance: Impact on blood safety
|
Emmanuel, Jean C. |
|
2010 |
38 |
1 |
p. 78-80 3 p. |
artikel |
20 |
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 – Conclusions and recommendations
|
WHO, |
|
2010 |
38 |
1 |
p. 170-177 8 p. |
artikel |
21 |
Microarray blood testing: Pros & cons
|
Petrik, Juraj |
|
2010 |
38 |
1 |
p. 2-8 7 p. |
artikel |
22 |
Nanotechnologies for pathogen detection: Future alternatives?
|
Fournier-Wirth, Chantal |
|
2010 |
38 |
1 |
p. 9-13 5 p. |
artikel |
23 |
Nomenclature and guideline to express the amount of a membrane protein synthesized in animal cells in view of bioprocess optimization and production monitoring
|
Augusto, Elisabeth F.P. |
|
2010 |
38 |
1 |
p. 105-112 8 p. |
artikel |
24 |
Nucleic acid testing (NAT) in high prevalence–low resource settings
|
El Ekiaby, Magdy |
|
2010 |
38 |
1 |
p. 59-64 6 p. |
artikel |
25 |
Optimal use of blood in trauma patients
|
Holcomb, John B. |
|
2010 |
38 |
1 |
p. 72-77 6 p. |
artikel |
26 |
Recruitment of blood donors in Burkina Faso: how to avoid donations from family members?
|
Dahourou, Honorine |
|
2010 |
38 |
1 |
p. 39-42 4 p. |
artikel |
27 |
Removal of TSE agents by depth or membrane filtration from plasma products
|
Roberts, Peter L. |
|
2010 |
38 |
1 |
p. 158-161 4 p. |
artikel |
28 |
Self-sufficiency, free trade and safety
|
Rautonen, Jukka |
|
2010 |
38 |
1 |
p. 97-99 3 p. |
artikel |
29 |
Should we neglect or nurture replacement blood donors in sub-Saharan Africa?
|
Bates, Imelda |
|
2010 |
38 |
1 |
p. 65-67 3 p. |
artikel |
30 |
Testing genotoxicity and cytotoxicity strategies for the evaluation of commercial radiosterilized fetal calf sera
|
Pilili, Juan Pablo |
|
2010 |
38 |
1 |
p. 135-143 9 p. |
artikel |
31 |
The effect of salt concentration on the prekallikrein activator assay
|
Georgakopoulos, Thanae |
|
2010 |
38 |
1 |
p. 178-179 2 p. |
artikel |
32 |
The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test
|
Jagt, H.J.M. |
|
2010 |
38 |
1 |
p. 128-134 7 p. |
artikel |
33 |
Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC
|
Mufti, N.A. |
|
2010 |
38 |
1 |
p. 14-19 6 p. |
artikel |
34 |
Whole blood and component use in resource poor settings
|
Marwaha, Neelam |
|
2010 |
38 |
1 |
p. 68-71 4 p. |
artikel |